1 results match your criteria: "Treatment Center of Sickle Cell Anemia[Affiliation]"
Hemoglobin
January 2008
Treatment Center of Sickle Cell Anemia, AP-HP, Hôpital Henri Mondor, Créteil, France.
Hydroxyurea (HU) is useful for treating sickle cell anemia because of its ability to reduce some of the severe clinical events such as painful crises and acute chest syndrome. It may also reduce the need for blood transfusions and frequent hospitalizations and reduce mortality. Nevertheless, no consistent recommendations regarding its therapeutic schedule are defined.
View Article and Find Full Text PDF